- Report
- April 2025
- 175 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- January 2026
- 191 Pages
Global
From €3436EUR$3,939USD£2,992GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1308EUR$1,500USD£1,140GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1090EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1090EUR$1,250USD£950GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1308EUR$1,500USD£1,140GBP
- Report
- April 2025
- 182 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1090EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1308EUR$1,500USD£1,140GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1745EUR$2,000USD£1,519GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1745EUR$2,000USD£1,519GBP
- Report
- January 2026
- 185 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- January 2026
- 180 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- June 2025
- 150 Pages
Global
From €2354EUR$2,699USD£2,050GBP
- Report
- June 2025
- 200 Pages
Global
From €2433EUR$2,789USD£2,119GBP
- Report
- August 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- July 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- May 2025
- 134 Pages
Global
From €15697EUR$17,995USD£13,671GBP
- Report
- February 2026
- 50 Pages
Global
From €2312EUR$2,650USD£2,013GBP
- Report
- February 2026
- 50 Pages
Global
From €2312EUR$2,650USD£2,013GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more